GLOBUS MEDICAL INC
GMEDGlobus Medical Inc. (GMED) is a leading medical device company specializing in the design, development, and commercialization of innovative products for the spine, trauma, and other orthopedic markets. Founded in 2003 and headquartered in Audubon, Pennsylvania, the company focuses on advancing patient care through its extensive portfolio of surgical solutions and technological innovations aimed at treating musculoskeletal conditions.
Company News
The global spinal implants market was valued at USD 11.5 billion in 2024 and is projected to reach USD 15.8 billion by 2030, growing at a CAGR of 5.5%. Growth is driven by an aging global population, rising traumatic injuries, and advancements in minimally invasive spine surgery. Spinal fusion devices dominate the market, while Asia Pacific is ex...
The global Pedicle Screw Systems Market is projected to grow from $2.38 billion in 2025 to $3.71 billion by 2033, with a 5.76% CAGR, driven by rising spinal disorder prevalence and technological advancements in spine surgery.
Multiple large-cap companies reported strong Q3 earnings and raised fiscal year guidance, leading to significant stock price gains across various sectors including technology, travel, and healthcare.
Globus Medical announced leadership transitions, with Keith Pfeil becoming President and CEO, replacing Dan Scavilla. Kyle Kline was appointed as the new CFO. The company reported preliminary Q2 2025 sales of $745.3 million, an 18.4% increase from the previous year.
The global intramedullary nail market is expected to grow rapidly, driven by the rising incidence of bone fractures, particularly among the aging population, and advancements in surgical techniques. However, the market faces challenges such as high procedural costs, the need for skilled professionals, and competition from alternative fixation dev...
